Medical Pharmacology Chapter 23: Ergot Alkaloids
Ergot Alkaloids: Clinical Pharmacology
|
|
Often accompanied by brief aura (visual scotomas, hemianopia, beach abnormalities
Severe, throbbing, usually unilateral headache (few hours to a few days in duration)
More common in women
Onset: early adolescence; less common in older patients
Migraine associated with stress
Headache frequency: Range -- to or more per week to once a year
|
|
Vasomotor mechanism is inferred from:
Increased temporal artery pulsation magnitude
Pain relief (by ergotamine) occurs with decreased artery pulsations
Migraine attack associated with (based on histological studies):
Sterile neurogenic perivascular edema
Inflammation (clinically effective antimigraine medication reduce perivascular inflammation)
Serotonin involvement (evidence for):
Throbbing headache: associated with decreased serum and platelet serotonin
Presence of serotonergic nerve terminals at meningeal blood vessels
Antimigraine drugs influence serotonergic neurotransmitter
Some migraine chemical triggers may work through serotonin pathways, i.e. decreasing estrogen (associated with the menstrual cycle) and increased prostaglandin E1.
Burkhalter, A, Julius, D.J. and Katzung, B. Histamine, Serotonin and the Ergot Alkaloids (Section IV. Drugs with Important Actions on Smooth Muscle), in Basic and Clinical Pharmacology, (Katzung, B. G., ed) Appleton-Lange, 1998, pp 261-286.; New "Triptans" and Other Drugs for Migraine, The Medical Letter, Vol. 40 (Issue 1037); October 9, 1998